|
1
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shoeb M: Anti-cancer agents from medicinal
plants. Bangladesh J Pharmacol. 1:35–41. 2006.
|
|
5
|
Balunas MJ and Kinghorn AD: Drug discovery
from medicinal plants. Life Sci. 78:431–441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaheen U, Ragab EA, Abdalla AN and Bader
A: Triterpenoidal saponins from the fruits of Gleditsia caspica
with proapoptotic properties. Phytochemistry. 145:168–178. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bader A, Tuccinardi T, Granchi C,
Martinelli A, Macchia M, Minutolo F, De Tommasi N and Braca A:
Phenylpropanoids and flavonoids from Phlomis kurdica as
inhibitors of human lactate dehydrogenase. Phytochemistry.
116:262–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malafronte N, Vasallo A, Dal Piaz F, Bader
A, Braca A and De Tommasi N: Biflavonoids from Daphne
linearifolia Hart. Phytochem Lett. 5:621–625. 2012. View Article : Google Scholar
|
|
9
|
Kerbel R and Folkman J: Clinical
translation of angiogenesis inhibitors. Nat Rev Cancer. 2:727–739.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sogno I, Venè R, Ferrari N, De Censi A,
Imperatori A, Noonan DM, Tosetti F and Albini A: Angioprevention
with fenretinide: Targeting angiogenesis in prevention and
therapeutic strategies. Crit Rev Oncol Hematol. 75:2–14. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Armulik A, Abramsson A and Betsholtz C:
Endothelial/pericyte interactions. Circ Res. 97:512–523. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El-Kenawi AE and El-Remessy AB:
Angiogenesis inhibitors in cancer therapy: Mechanistic perspective
on classification and treatment rationales. Br J Pharmacol.
170:712–729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abdollahi A, Lipson KE, Sckell A, Zieher
H, Klenke F, Poerschke D, Roth A, Han X, Krix M, Bischof M, et al:
Combined therapy with direct and indirect angiogenesis inhibition
results in enhanced anti-angiogenic and antitumor effects. Cancer
Res. 63:8890–8898. 2003.PubMed/NCBI
|
|
14
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown KJ, Maynes SF, Bezos A, Maguire DJ,
Ford MD and Parish CR: A novel in vitro assay for human
angiogenesis. Lab Invest. 75:539–555. 1996.PubMed/NCBI
|
|
16
|
Nicosia RF, Lin YJ, Hazelton D and Qian X:
Endogenous regulation of angiogenesis in the rat aorta model. Role
of vascular endothelial growth factor. Am J Pathol. 151:1379–1386.
1997.PubMed/NCBI
|
|
17
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zihlif M, Afifi F, Abu-Dahab R, Majid
Abdul AM, Somrain H, Saleh MM, Nassar ZD and Naffa R: The
anti-angiogenic activities of ethanolic crude extracts of four
Salvia species. BMC Complement Altern Med. 13:3582013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hurwitz H, Fehrenbacher L, Novotny W,
Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S,
Holmgren E, et al: Bevacizumab plus irinotecan, fluorouracil, and
leucovorin for metastatic colorectal cancer. N Engl J Med.
350:2335–2342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dal Piaz F, Vassallo A, Lepore L, Tosco A,
Bader A and De Tommasi N: Sesterterpenes as tubulin tyrosine ligase
inhibitors. First insight of structure-activity relationships and
discovery of new lead. J Med Chem. 52:3814–3828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Atmaca H and Bozkurt E: Apoptotic and
anti-angiogenic effects of Salvia triloba extract in
prostate cancer cell lines. Tumour Biol. 37:3639–3646. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zihlif M, Afifi F, Muhtaseb R, Al-Khatib
S, Abaza I and Naffa R: Screening the anti-angiogenic activity of
medicinal plants grown and sold in Jordan. Planta Med. 78:297–301.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baker M, Robinson SD, Lechertier T, Barber
PR, Tavora B, D'Amico G, Jones DT, Vojnovic B and Hodivala-Dilke K:
Use of the mouse aortic ring assay to study angiogenesis. Nat
Protoc. 7:89–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Folkman J, Hahnfeldt P and Hlatky L: The
logic of anti-angiogenic gene therapy. 36. Cold Spring Harbor
Monograph Series; pp. 527–544. 1999
|
|
26
|
Yoshiji H, Harris SR and Thorgeirsson UP:
Vascular endothelial growth factor is essential for initial but not
continued in vivo growth of human breast carcinoma cells. Cancer
Res. 57:3924–3928. 1997.PubMed/NCBI
|
|
27
|
Başer KHC: Biological and pharmacological
activities of carvacrol and carvacrol bearing essential oils. Curr
Pharm Des. 14:3106–3119. 2008.(Review). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adzet T and Martinez F: Flavonoids in the
leaves of Thymus: A chemotaxonomic survey. Biochem Syst Ecol.
9:293–295. 1981. View Article : Google Scholar
|
|
29
|
Gong Y, Li Y, Lu Y, Li L, Abdolmaleky H,
Blackburn GL and Zhou JR: Bioactive tanshinones in Salvia
miltiorrhiza inhibit the growth of prostate cancer cells in vitro
and in mice. Int J Cancer. 129:1042–1052. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bader A, Cioni PL, De Tommasi N and
Flamini G: Essential oil compositions of two populations of
Salvia samuelssonii growing in different biogeographical
regions of Jordan. Nat Prod Commun. 9:141–143. 2014.PubMed/NCBI
|
|
31
|
Çaliş I, Kirmizibekmez H, Taşdemir D and
Rüedi P: Two new triterpene and a new nortriterpene glycosides from
Phlomis viscose. Helv Chim Acta. 87:611–619. 2004.
View Article : Google Scholar
|
|
32
|
Çaliş I, Kirmizibekmez H, Beutler JA,
Dönmez AA, Yalçin FN, Kiliç E, Özalp M, Rüedi P and Taşdemir D:
Secondary metabolites of Phlomis viscosa and their
biological activities. Turk J Chem. 29:71–81. 2005.
|
|
33
|
Albadawi DA, Mothana RA, Khaled JM, Ashour
AE, Kumar A, Ahmad SF, Al-Said MS, Al-Rehaily AJ and Almusayeib NM:
Antimicrobial, anticancer, and antioxidant compounds from Premna
resinosa growing in Saudi Arabia. Pharm Biol. 55:1759–1766. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ulubelen A, Topçu G and Johansson CB:
Norditerpenoids and diterpenoids from Salvia multicaulis
with antituberculous activity. J Nat Prod. 60:1275–1280. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kharazian N: Chemotaxonomy and flavonoid
diversity of Salvia L. (Lamiaceae) in Iran. Acta Bot Bras.
28:281–292. 2014. View Article : Google Scholar
|
|
36
|
Ulubelen A, Oksüz S, Kolak U, Birman H and
Voelter W: Cardioactive terpenoids and a new rearranged diterpene
from Salvia syriaca. Planta Med. 66:627–629. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Al-Jaber HI, Abrouni KK, Al-Qudah MA and
Abu Zarga MH: New terpenes from Salvia palaestina Benth. and
Salvia syriaca L. growing wild in Jordan. J Asian Nat Prod
Res. 14:618–625. 2012. View Article : Google Scholar : PubMed/NCBI
|
